Oxford BioDynamics (LON:OBD) Stock Price Down 19.8% – Here’s Why

Oxford BioDynamics Plc (LON:OBD)’s share price fell 19.8% during mid-day trading on Friday . The stock traded as low as GBX 0.12 and last traded at GBX 0.14. 29,025,111 shares changed hands during mid-day trading, an increase of 102% from the average session volume of 14,404,227 shares. The stock had previously closed at GBX 0.17.

Oxford BioDynamics Stock Performance

The stock has a market cap of £5.92 million, a P/E ratio of -0.17 and a beta of 0.42. The company has a fifty day moving average of GBX 0.19 and a 200 day moving average of GBX 0.23. The company has a debt-to-equity ratio of 457.97, a current ratio of 0.88 and a quick ratio of 2.80.

About Oxford BioDynamics

Oxford BioDynamics Plc is a global biotechnology company, advancing personalized healthcare by developing and commercializing precision medicine tests for life-changing diseases.

Its flagship product is EpiSwitch® CiRT (Checkpoint Inhibitor Response Test) for cancer, a predictive immune response profile for immuno-oncology (IO) checkpoint inhibitor treatments, launched in February 2022.

In March 2021, the Company launched its first commercial prognostic test, EpiSwitch® CST (Covid Severity Test) and the first commercially available microarray kit for high-resolution 3D genome profiling and biomarker discovery, EpiSwitch® Explorer Array Kit.